United States · FDA National Drug Code directory

Novo Nordisk

Labeler · 69 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 0169-7705_b67c2419-4feb-4ce1-b97e-88760a8e1aee

Norditropin

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-7708_b67c2419-4feb-4ce1-b97e-88760a8e1aee

Norditropin

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2200_ecfd53fb-5887-48df-bc66-c32f8ff0cf67

NovoLog Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-2201_ecfd53fb-5887-48df-bc66-c32f8ff0cf67

NovoLog Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-3685_ecfd53fb-5887-48df-bc66-c32f8ff0cf67

NovoLog Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-3696_ecfd53fb-5887-48df-bc66-c32f8ff0cf67

NovoLog Mix 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-7010_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7020_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7040_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7050_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7201_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7202_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7205_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-7208_eeebef79-2f60-467f-b01f-58a34f0a8175

NovoSeven RT

KIT / Novo Nordisk

United States · Source reference 0169-1837_c7164ea1-aa3e-4359-a3f0-a34c78e78398

Novolin 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-3007_c7164ea1-aa3e-4359-a3f0-a34c78e78398

Novolin 70/30

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-1834_652d3fd6-809f-476e-9159-a1beffb9ea01

Novolin N

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-3004_652d3fd6-809f-476e-9159-a1beffb9ea01

Novolin N

INJECTION, SUSPENSION / Novo Nordisk

United States · Source reference 0169-1833_46700b71-3f26-4aaa-8eb7-6ceeeb515c79

Novolin R

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-3003_46700b71-3f26-4aaa-8eb7-6ceeeb515c79

Novolin R

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-7901_4d658384-07d9-471f-8b15-16b8cec36765

REBINYN

KIT / Novo Nordisk

United States · Source reference 0169-7902_4d658384-07d9-471f-8b15-16b8cec36765

REBINYN

KIT / Novo Nordisk

United States · Source reference 0169-7903_4d658384-07d9-471f-8b15-16b8cec36765

REBINYN

KIT / Novo Nordisk

United States · Source reference 0169-7905_4d658384-07d9-471f-8b15-16b8cec36765

REBINYN

KIT / Novo Nordisk

United States · Source reference 0169-5306_758d66fb-0447-4f26-905f-595b182aebdc

RIVFLOZA

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-5307_758d66fb-0447-4f26-905f-595b182aebdc

RIVFLOZA

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-5308_758d66fb-0447-4f26-905f-595b182aebdc

RIVFLOZA

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2030_02935ecf-5395-4b9b-9b2f-75d59ca651f3

SOGROYA

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2035_02935ecf-5395-4b9b-9b2f-75d59ca651f3

SOGROYA

INJECTION, SOLUTION / Novo Nordisk

United States · Source reference 0169-2037_02935ecf-5395-4b9b-9b2f-75d59ca651f3

SOGROYA

INJECTION, SOLUTION / Novo Nordisk

Browse companies in United States →